Norway and Denmark suspend coronavirus vaccination with a drug from the British-Swedish company AstraZeneca.
As reported by TASS, this decision was made after the appearance of data on the formation of blood clots in those vaccinated and allegedly associated with this fatal case in Denmark.
“Due to the reported death in Denmark due to a blood clot following the introduction of the AstraZeneca vaccine, Norway has decided to suspend vaccination with the drug,” the Norwegian Institute of Health said in a statement.
According to Danish doctors, the European Medicines Agency (EMA) has begun research on the drug, but “it is currently impossible to conclude whether there is a link between the vaccine and blood clots.”
Earlier it was reported that the EMA did not identify problems with the batch of the AstraZeneca vaccine, the use of which was suspended after the occurrence of complications in those vaccinated in Austria.